ZA921575B - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number: ZA921575B
Authority: ZA; South Africa
Prior art keywords: pharmaceuticals
Prior art date: 1991-03-05

Application number

ZA921575A

Other languages

English (en)

Inventor

Giuseppe Giardina

Giardina Giuseppe

Geoffrey Douglas Clarke

Douglas Clarke Geoffrey

Original Assignee

Zambeletti Spa L

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-05

Filing date

1992-03-03

Publication date

1992-12-30

1992-03-03 Application filed by Zambeletti Spa L filed Critical Zambeletti Spa L

1992-12-30 Publication of ZA921575B publication Critical patent/ZA921575B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA921575A 1991-03-05 1992-03-03 Pharmaceuticals ZA921575B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB919104656A GB9104656D0 (en)	1991-03-05	1991-03-05	Pharmaceuticals

Publications (1)

Publication Number	Publication Date
ZA921575B true ZA921575B (en)	1992-12-30

Family

ID=10691041

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA921575A ZA921575B (en)	1991-03-05	1992-03-03	Pharmaceuticals

Country Status (8)

Country	Link
EP (1)	EP0574477A1 (xx)
CA (1)	CA2105589A1 (xx)
GB (1)	GB9104656D0 (xx)
IE (1)	IE920679A1 (xx)
MX (1)	MX9200948A (xx)
PT (1)	PT100188A (xx)
WO (1)	WO1992015304A2 (xx)
ZA (1)	ZA921575B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8926560D0 (en) *	1989-11-24	1990-01-17	Zambeletti Spa L	Pharmaceuticals
AU7681491A (en) *	1990-04-28	1991-11-27	Dr. Lo Zambeletti S.P.A.	Novel 1-(2h-1-oxo-3,4-dihydronaphtyl-6)-acetyl-piperidines, process for their preparation and therapeutic use
US7381750B2 (en)	2004-03-12	2008-06-03	Eli Lilly And Company	Amino-phenoxymethyl-benzamide opioid receptor antagonists
US7615556B2 (en)	2006-01-27	2009-11-10	Bristol-Myers Squibb Company	Piperazinyl derivatives as modulators of chemokine receptor activity
US7601844B2 (en)	2006-01-27	2009-10-13	Bristol-Myers Squibb Company	Piperidinyl derivatives as modulators of chemokine receptor activity
TWI433838B (zh)	2008-06-25	2014-04-11	必治妥美雅史谷比公司	作為趨化因子受體活性調節劑之六氫吡啶衍生物
WO2011140425A1 (en)	2010-05-06	2011-11-10	Vertex Pharmaceuticals Incorporated	Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
US8642622B2 (en)	2010-06-16	2014-02-04	Bristol-Myers Squibb Company	Piperidinyl compound as a modulator of chemokine receptor activity
TW201604196A (zh)	2011-02-02	2016-02-01	維泰克斯製藥公司	作為離子通道調節劑之吡咯并吡－螺環哌啶醯胺
US10385070B2 (en)	2011-02-18	2019-08-20	Vertex Pharmaceuticals Incorporated	Chroman-spirocyclic piperidine amides as modulators of ion channels
EP2686325B1 (en)	2011-03-14	2016-12-14	Vertex Pharmaceuticals Incorporated	Morpholine-spirocyclic piperidine amides as modulators of ion channels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH02138254A (ja) *	1988-02-23	1990-05-28	Glaxo Group Ltd	複素環誘導体
GB8804104D0 (en) *	1988-02-23	1988-03-23	Glaxo Group Ltd	Chemical compounds
EP0330468A3 (en) *	1988-02-23	1991-04-03	Glaxo Group Limited	Use of heterocyclic derivatives as kappa-opioid receptor agonists in the treatment of cerebral ischaemia
GB8813714D0 (en) *	1988-06-09	1988-07-13	Glaxo Group Ltd	Chemical compounds
EP0361791B1 (en) *	1988-09-26	1995-11-08	Smithkline Beecham Farmaceutici S.p.A.	Azacyclic derivatives useful as medicaments

1991
- 1991-03-05 GB GB919104656A patent/GB9104656D0/en active Pending
1992
- 1992-03-02 PT PT100188A patent/PT100188A/pt not_active Application Discontinuation
- 1992-03-03 ZA ZA921575A patent/ZA921575B/xx unknown
- 1992-03-03 IE IE067992A patent/IE920679A1/en not_active Application Discontinuation
- 1992-03-04 MX MX9200948A patent/MX9200948A/es unknown
- 1992-03-04 WO PCT/EP1992/000492 patent/WO1992015304A2/en not_active Ceased
- 1992-03-04 CA CA002105589A patent/CA2105589A1/en not_active Abandoned
- 1992-03-04 EP EP92906079A patent/EP0574477A1/en not_active Withdrawn

Also Published As

Publication number	Publication date
PT100188A (pt)	1993-05-31
WO1992015304A3 (en)	1993-06-24
EP0574477A1 (en)	1993-12-22
CA2105589A1 (en)	1992-09-06
MX9200948A (es)	1992-11-01
GB9104656D0 (en)	1991-04-17
IE920679A1 (en)	1992-09-09
WO1992015304A2 (en)	1992-09-17

Publication	Publication Date	Title
GB9103839D0 (en)	1991-04-10	Pharmaceuticals
GB9121835D0 (en)	1991-11-27	Pharmaceuticals
GB9104656D0 (en)	1991-04-17	Pharmaceuticals
ZA92343B (en)	1992-12-30	Pharmaceuticals
GB9121170D0 (en)	1991-11-20	Pharmaceuticals
AP9200422A0 (en)	1992-10-31	Pharmaceuticals
GB9119692D0 (en)	1991-10-30	Pharmaceuticals
GB9107896D0 (en)	1991-05-29	Pharmaceuticals
GB9110774D0 (en)	1991-07-10	Pharmaceuticals
GB9126436D0 (en)	1992-02-12	Pharmaceuticals
GB9127185D0 (en)	1992-02-19	Pharmaceuticals
GB9127202D0 (en)	1992-02-19	Pharmaceuticals
GB9114171D0 (en)	1991-08-21	Pharmaceuticals
GB9115125D0 (en)	1991-08-28	Pharmaceuticals
GB9127184D0 (en)	1992-02-19	Pharmaceuticals
GB9116891D0 (en)	1991-09-18	Pharmaceuticals
GB9117646D0 (en)	1991-10-02	Pharmaceuticals
GB9119449D0 (en)	1991-10-23	Pharmaceuticals
GB9102656D0 (en)	1991-03-27	Pharmaceuticals
GB9120188D0 (en)	1991-11-06	Pharmaceuticals
GB9100370D0 (en)	1991-02-20	Pharmaceuticals
GB9100580D0 (en)	1991-02-20	Pharmaceuticals
IL99080A0 (en)	1992-07-15	Pharmaceuticals
GB9120390D0 (en)	1991-11-06	Pharmaceuticals
GB9110990D0 (en)	1991-07-10	Pharmaceuticals